| Dr Jeffery L Jones, MD | |
|
985 9th Ave Sw, Ste. 307, Bessemer, AL 35022-7809 | |
| (205) 481-7384 | |
| (205) 481-7389 |
| Full Name | Dr Jeffery L Jones |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 19 Years |
| Location | 985 9th Ave Sw, Bessemer, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295948982 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical West, An Affiliate Of Uab Health System | Bessemer, AL | Hospital |
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical West Hospital Authority, An Affiliate Of Uab Health System | 6406865427 | 68 |
News Archive
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.
Today's headlines include coverage of a new report that offers a gloomy fiscal forecast for states as they confront rising health care costs, underfunded pensions and a range of other economic challenges.
Impax Laboratories, Inc. today announced that on November 20, the Company's development and manufacturing partner received final approval by the U.S. Food and Drug Administration for a generic version of dutasteride capsules, 0.5 mg.
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
A partnership between a New York City dental school and a local foster care agency has provided consistent dental care to more than 650 children, and may serve as a model for other dental school program curriculums. The success of Partners Against Caries (PAC), both for the participating foster children and dental school students, was outlined Oct. 21 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans.
› Verified 4 days ago
| Entity Name | Medical West Hospital Authority, An Affiliate Of Uab Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952483729 PECOS PAC ID: 6406865427 Enrollment ID: O20061204000666 |
News Archive
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.
Today's headlines include coverage of a new report that offers a gloomy fiscal forecast for states as they confront rising health care costs, underfunded pensions and a range of other economic challenges.
Impax Laboratories, Inc. today announced that on November 20, the Company's development and manufacturing partner received final approval by the U.S. Food and Drug Administration for a generic version of dutasteride capsules, 0.5 mg.
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
A partnership between a New York City dental school and a local foster care agency has provided consistent dental care to more than 650 children, and may serve as a model for other dental school program curriculums. The success of Partners Against Caries (PAC), both for the participating foster children and dental school students, was outlined Oct. 21 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffery L Jones, MD 985 9th Ave Sw, Ste. 307, Bessemer, AL 35022-7809 Ph: (205) 481-7384 | Dr Jeffery L Jones, MD 985 9th Ave Sw, Ste. 307, Bessemer, AL 35022-7809 Ph: (205) 481-7384 |
News Archive
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.
Today's headlines include coverage of a new report that offers a gloomy fiscal forecast for states as they confront rising health care costs, underfunded pensions and a range of other economic challenges.
Impax Laboratories, Inc. today announced that on November 20, the Company's development and manufacturing partner received final approval by the U.S. Food and Drug Administration for a generic version of dutasteride capsules, 0.5 mg.
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
A partnership between a New York City dental school and a local foster care agency has provided consistent dental care to more than 650 children, and may serve as a model for other dental school program curriculums. The success of Partners Against Caries (PAC), both for the participating foster children and dental school students, was outlined Oct. 21 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans.
› Verified 4 days ago
Jane Ann Gehlsen, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 985 9th Ave Sw, Suite 404, Bessemer, AL 35022 Phone: 205-481-8475 Fax: 205-481-8478 | |
Richard Timothy Mcglaughlin, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 985 9th Ave Sw Ste 307, Bessemer, AL 35022 Phone: 205-481-7384 Fax: 205-481-7389 | |
Jonathon Tyler Baccus, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 915 Medical Center Dr, Bessemer, AL 35022 Phone: 205-481-8664 Fax: 205-481-8665 | |
Julie Ann Zitterkopf Larson, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 985 9th Ave Sw, Bessemer, AL 35022 Phone: 205-481-7000 | |
Dr. Michael Arthur Moore, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 927 Medical Center Dr, Bessemer, AL 35022 Phone: 205-481-8670 Fax: 205-424-4927 | |
Dr. Daniel Vincent Kyle, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2201 Arlington Ave, Bessemer, AL 35020 Phone: 205-246-0001 Fax: 205-497-9369 | |
Dr. Wiley Kemp Livingston Jr., M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 927 Medical Center Dr, Bessemer, AL 35022 Phone: 205-481-8670 |